Genetic Technologies is a biotechnology company specializing in predictive genetic testing for chronic diseases and cancers. Its services include risk assessments for conditions such as breast, colorectal, ovarian, pancreatic, and prostate cancers, as well as coronary artery disease, type 2 diabetes, melanoma, and atrial fibrillation. These assessments integrate genetic data with clinical and familial information to provide personalized risk profiles.